Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.16% | 0.94% | -2.60% | -2.32% | 1.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.16% | 0.94% | -2.60% | -2.32% | 1.67% |
| Cost of Revenue | 0.94% | 3.81% | -1.53% | -1.88% | 1.11% |
| Gross Profit | -2.21% | -6.80% | -5.81% | -3.65% | 3.39% |
| SG&A Expenses | -6.18% | -1.64% | -3.78% | -1.60% | 0.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 169.49% | 51.63% | -362.18% | -406.30% | -355.05% |
| Total Operating Expenses | -0.02% | 3.06% | -3.58% | -2.78% | 0.44% |
| Operating Income | 2.37% | -18.33% | 9.72% | 3.43% | 19.29% |
| Income Before Tax | 53.95% | -48.30% | 63.20% | 21.58% | -10.43% |
| Income Tax Expenses | 49.77% | -30.14% | 33.08% | 20.67% | -10.14% |
| Earnings from Continuing Operations | 55.35% | -54.42% | 81.32% | 21.96% | -10.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 21.42% | 26.15% | 17.91% | 3.24% | -0.94% |
| Net Income | 106.59% | -64.75% | 155.09% | 31.76% | -16.83% |
| EBIT | 2.37% | -18.33% | 9.72% | 3.43% | 19.29% |
| EBITDA | -1.11% | -14.78% | 2.46% | -15.27% | 1.86% |
| EPS Basic | 106.63% | -64.76% | 155.10% | 31.76% | -16.83% |
| Normalized Basic EPS | 24.80% | -10.34% | 30.82% | 2.12% | 34.76% |
| EPS Diluted | 108.21% | -65.97% | 155.10% | 31.76% | -16.24% |
| Normalized Diluted EPS | 24.80% | -10.34% | 30.82% | 2.12% | 34.76% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | 19.82% | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -0.20% | -- |